An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac

Stefano Bianchi1, Sara Corradetti2

  • 1Fatebenefratelli Isola Tiberina Hospital, Rome.

Insights

Atrioventricular node ablation combined with cardiac resynchronization therapy (CRT) offers a definitive solution for heart failure patients with atrial fibrillation. This approach improves symptoms and survival, especially when other treatments fail.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Coexistence of heart failure and atrial fibrillation significantly worsens patient prognosis and quality of life.
  • Managing combined heart failure and atrial fibrillation presents ongoing clinical challenges.
  • Standard treatments for atrial fibrillation are often ineffective or unsuitable for these complex patients.

Purpose of the Study:

  • To evaluate the efficacy of atrioventricular node ablation combined with cardiac resynchronization therapy (CRT) as a definitive treatment.
  • To assess the impact of this strategy on symptom reduction and mortality in heart failure patients with atrial fibrillation.
  • To explore the utility of this approach in achieving optimal biventricular pacing for CRT-eligible patients with atrial fibrillation.

Main Methods:

  • Retrospective analysis of patients with heart failure and atrial fibrillation ineligible for standard ablation or refractory to medical therapy.
  • Implementation of atrioventricular node ablation.
  • Concomitant application of cardiac resynchronization therapy (CRT).

Main Results:

  • Demonstrated long-term positive outcomes in terms of significant symptom reduction.
  • Evidence of improved survival rates in patients undergoing the combined procedure.
  • Successful achievement of adequate biventricular pacing, enabling CRT benefits in previously ineligible patients.

Conclusions:

  • Atrioventricular node ablation with CRT is an effective definitive solution for select heart failure patients with atrial fibrillation.
  • This strategy offers substantial benefits in symptom control and mortality reduction.
  • It provides a viable option for achieving CRT eligibility in patients with concomitant atrial fibrillation.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
29
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
485
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19